Balanced Pharma
Growth Stage
Reinventing medical and dental injections for a better patient experience
Overview
Raised: $572,572
Total Commitments ($USD)
Platform
Dalmore Group
Start Date
04/10/2022
Close Date
Not Provided
Min. Goal
$100
Max. Goal
$25,000,000
Min. Investment
$100
Security Type
Equity - Common
Series
Seed
SEC Filing Type
RegA+
Price Per Share
$4.00
Pre-Money Valuation
$82,440,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
11/04/2023
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,008
# of Investors
47
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2020
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
Low
Balanced Pharma is raising funds on Dalmore Group through Reg A+ crowdfunding. The company intends to develop and sell a drug named Libracaine Dental. It is a pH-balanced injectable local anesthetic to be used for dental procedures. The drug is in the development phase and will be used to save time for dentists, reduce pain for patients, and improve the patient experience. J. Scott Keadle founded Balanced Pharma in 2020. The current crowdfunding campaign has no minimum target and a maximum target of $25,000,000. The campaign proceeds will be used for product development, product manufacturing, product marketing and disease awareness, intellectual property development, and general and administrative purposes.
Balance Sheet
|
Cash and Cash Equivalents |
$1,616,810 |
|
Investment Securities |
$0 |
| Total Assets |
$1,696,346 |
|
Accounts Payable & Accrued Liabilities |
$3,558 |
|
Long Term Debt |
$0 |
|
Total Liabilities |
$3,588 |
|
Total Stockholders' Equity |
$1,692,758 |
| Total Liabilities and Equity |
$1,696,346 |
Statement of Comprehensive Income Information
| Net Income |
$-900,980 |
|
Earnings Per Share - Basic |
$-0.05 |
|
Earnings Per Share - Diluted |
$-0.05 |
Auditor: Artesian CPA, LLC
Financials as of: 04/10/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.